Assess metabolic stability, drug-metabolizing enzyme interaction, and identify major metabolites to complement the distribution data.
Learn More →At Creative Biolabs, we provide comprehensive distribution analysis services and the quantitative data required to move beyond the apparent volume of distribution to help our clients understand the pharmacokinetic behavior of their drugs. Our team of experienced scientists has extensive knowledge in drug distribution analysis and offers consulting services to help you tailor drug distribution assay solutions and interpret the results of your distribution assays.
Drug distribution specifically refers to that a drug is spread and transport throughout the various tissues and organs in the body after it is absorbed into the bloodstream. Drug distribution analysis in vitro is a crucial step in the drug development process. The distribution assays help researchers predict how a drug will behave in vivo, or in a living organism. It is crucial to understand the pharmacokinetic properties of a drug and determine the effective dose of a drug, its safety profile, and its potential therapeutic efficacy.
Discover how we can advance your program - Request a consultation.
Fig.1 Models of probable drug substance distribution patterns in SLMs. 1
At Creative Biolabs, our drug distribution analysis services are designed to simulate the physiological conditions of the human body, providing insights into how drugs interact with tissues and organs. Using state-of-the-art instrumentation and validated methods, we analyze the distribution of drugs in vitro, allowing for predictions of in vivo behavior. Several in vitro drug distribution assays are available at our lab, including:
| Protein Binding Assays | Red Blood Cell (RBC) Partitioning Assay |
|---|---|
Protein binding can affect the distribution of a drug in the body. At Creative Biolabs, we typically use blood, microsomes, tissue homogenates, and animal or human cells to study the distribution of a drug in specific cell types or tissues. To determine the drug distribution, we offer the following protein binding assays:
|
Red blood cells can serve as a reservoir for certain drugs, affecting their overall distribution and pharmacokinetics in the body. The RBC partitioning assay provides valuable insights into the distribution of drugs within the blood compartment, specifically the ratio of whole blood to plasma. It can help in understanding the extent to which a drug binds to red blood cells, which may affect its distribution to different organs and tissues. |
We offer an integrated, full-spectrum service from foundational in vitro binding profiles to in vivo tissue mapping, ensuring a seamless, high-quality data chain for building robust preclinical data packages.
We utilize our proprietary binding prediction technology to reliably differentiate between molecules that exhibit extremely high plasma binding, providing the necessary resolution where conventional methods often fail.
Every project is managed by dedicated ADME experts who collaborate with you to define highly customized PK/PD study designs, perfectly tailored to your molecule's unique profile and specific research objectives.
We maintain the capability for high-magnification analysis, including cellular-level visualization, to deliver precise, sub-organ distribution data for anatomically restricted or specialized areas, such as ocular tissue or specific CNS regions.
Experience the Creative Biolabs advantage - Secure a formal quotation today.
A: At Creative Biolabs, our blood/tissues are from several species, including human, rodent, and non-rodent species such as human, mouse, rat, rabbit, and monkey.
A: Plasma protein binding of compounds is frequently evaluated using a range of techniques, such as equilibrium dialysis, ultrafiltration, ultracentrifugation, and flux dialysis. Equilibrium dialysis is the most common method among them. The choice of method depends on the specific drug properties and the needs of your projects.
Assess metabolic stability, drug-metabolizing enzyme interaction, and identify major metabolites to complement the distribution data.
Learn More →Detailed LC-MS and NMR-based services for the structural elucidation and quantification of circulating and tissue-bound metabolites, which are critical for safety assessment and understanding drug pathways.
Learn More →To cease reliance on empirical assumptions and commence the rigorous quantification of a compound's actual tissue distribution, the ADME specialists at Creative Biolabs stand prepared to offer comprehensive guidance and bespoke study design, ensuring the fulfillment of all necessary regulatory and developmental requirements. If you require drug distribution analysis, please contact us now.
Reference